glp-1 agonist side effects The expanding role of receptor agonists: a narrative review of current evidence and future directions What are the side effects
Description
Berglund LM, Lyssenko V, Ladenvall C, Kotova O, Edsfeldt A, Pilgaard K, et al
A recent study involving 3,390 people taking semaglutide or liraglutide found participants who took high doses of their drug 1.7 mg, 2.0 mg or 2.4 mg of semaglutide, or 3 mg of liraglutide lost more weight after a year compared to people taking lower doses
Pfizers PF-07976016 Pfizer was once the most aggressive challenger in the oral GLP-1 race
& Westermark, G
And, if this helps people (and one of my clients most definitely has been helped!) that is great
